Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Mega Lifesciences (Australia) Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (87)
Cancellation by sponsor (9)
Listed medicine compliance report (1)

Date

2025 (2)
2024 (8)
2023 (9)
2022 (3)
2021 (16)
2020 (6)
2019 (8)
2018 (11)
2017 (7)
2016 (2)
2014 (8)
2011 (4)
2010 (4)
2009 (2)
2007 (5)
2006 (2)

Search

Sponsor content

97 result(s) found, displaying 41 to 50

BiO-LiFE CoQ10 300 mg Soft Capsules (322099)

21 August 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BiO-LiFE CoQ10 300 mg Soft Capsules.
LIVOLIN-H CAPSULES (319461)

1 July 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LIVOLIN-H CAPSULES.
Meo Healthcare Magnesium Citrate Plus Cancelled under Section 30(1)(c) of the Act

3 June 2021

Cancellation by sponsor

Requested by Mega Lifesciences (Australia) Pty Ltd
Mega Lifesciences Lysine with Multivitamins Chewable Tablet Cancelled under Section 30(1)(c) of the Act

29 April 2021

Cancellation by sponsor

Requested by Mega Lifesciences (Australia) Pty Ltd
Curcumin Phytosome Tablets Cancelled under Section 30(1)(c) of the Act

29 April 2021

Cancellation by sponsor

Requested by Mega Lifesciences (Australia) Pty Ltd
BIO ZINC COMPLEX TABLETS Cancelled under Section 30(1)(c) of the Act

29 April 2021

Cancellation by sponsor

Requested by Mega Lifesciences (Australia) Pty Ltd
Milk Thistle & Dandelion Tablet Cancelled under Section 30(1)(c) of the Act

29 April 2021

Cancellation by sponsor

Requested by Mega Lifesciences (Australia) Pty Ltd
Bio-Life Celery 3000 Cancelled under Section 30(1)(c) of the Act

29 April 2021

Cancellation by sponsor

Requested by Mega Lifesciences (Australia) Pty Ltd
Saw Palmetto & Pumpkin Seed Cancelled under Section 30(1)(c) of the Act

29 April 2021

Cancellation by sponsor

Requested by Mega Lifesciences (Australia) Pty Ltd
Giloba (315644)

22 March 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Giloba.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.